Press Releases

The Global Market Value Of DNA Sequencing Expected To Increase To More Than $3.3 Billion In 2015

August 10, 2010

Additional Reports


Wellesley, Mass. – According to a new technical market research report, DNA SEQUENCING:EMERGING TECHNOLOGIES AND APPLICATIONS (BIO045C) from BCC Research (, the global market value of DNA sequencing products is an estimated $1.3 billion in 2010, but is expected to increase to more than $3.3 billion in 2015, for a 5-year compound annual growth rate (CAGR) of 20.5%.

The largest segment in the market, research drug discovery/development, is expected to increase at a CAGR of 13%, from $920 million in 2010 to $1.7 billion in 2015.

The second-largest segment in the market, made up of commercial applications, is estimated to be valued at nearly $242 million in 2010, and to increase to $615 million in 2015 at a CAGR of 20.6%.

The next-largest segment, made up of workflow solutions, is expected to increase at a healthy CAGR of 20.9% to reach $497 million. The 2010 value is estimated at $139 million.

The segment made up of emerging applications is projected to rise in value at a CAGR of 103.5%, increasing from an estimated $15.5 million in 2010 to more than $541 million in 2015.

DNA sequencing is a strategic genomics tool that allows us to study how the genome varies among individuals and how that variation correlates to disease. Sequencing technologies are critical parts of today’s life-science industry, affecting a wide range of activity from drug discovery to diagnostics.  The sequencing industry is undergoing major shifts in technology, applications, and markets that will change how genomics is done in the future.

BCC’s goal for this study is to determine the status of current- and newer-generation DNA (deoxyribonucleic acid) sequencing technologies, products and services and to assess their worldwide growth potential through 2015.

Sequencing applications market segments that will provide substantial future growth opportunities for next-generation DNA sequencing companies include research, drug discovery and development, bacterial genomics, agricultural genomics, clinical diagnostics, and personal genomics. Applications providing growth opportunities for genomics suppliers include sequence capture and bioinformatics.

The report will be of particular interest to life-science research tools suppliers, and pharmaceutical, diagnostics, nanotechnology, bioinformatics, semiconductor, and biotechnology companies.  It will also be of value to companies involved in genome-sequencing projects, sequencing centers, manufacturers of microarrays, suppliers of molecular diagnostics assays, bioinformatics companies, and cancer researchers and clinicians.

Source: BCC Research

DNA Sequencing: Emerging Technologies and Applications( BIO045C )
Publish Date: Jul 2010    

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC, 49 Walnut Park, Building 2, Wellesley, MA 02481, Telephone: 866-285-7215; Email: as the source and publisher. Thank you.